Greenland Mines Ltd (GRML)
Greenland Mines Ltd (GRML) Stock Price, Analysis & Data
| Bid | 0.2 |
| Market Cap | 30.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.29M |
| Beta | 2.56 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 0.48 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 0.18 |
| Volume | 2,071,040 |
| Avg. Volume (20D) | 5,450,258 |
| Open | 0.21 |
| Previous Close | 0.21 |
| Day's Range | 0.20 - 0.22 |
| 52-Week Range | 0.16 - 0.95 |
| Analyst | n/a |
| Price Target | 2.5 (1150.00%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About GRML
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention...
Financial Performance
In undefined, Greenland Mines Ltd's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for GRML stock is "null". The 12-month stock price forecast is 2.5, which is upside of 1150% from the latest price.
Stock Forecasts